Gary Sweeney

Gary Sweeney

Company: Allysta Pharmaceuticals Inc. & York University

Job title: Scientific Advisory Board Member & Professor

Seminars:

Panel & Audience Discussion: What’s Next for Fibrosis? Understanding the Future Directions of the Antifibrotic Field 3:00 pm

This panel brings together experts from across various disease indications to explore the evolving scientific, translational, and clinical landscape of antifibrotic drug development to provide forward-looking perspective on where antifibrotic science is heading, which challenges are most urgent to overcome, and how industry and academia can collaborate more effectively to accelerate progress across diverse indication.…Read more

day: Conference Day Two

Reducing Multi-Organ Fibrosis Through Adiponectin Signaling to Restore Metabolic Homeostasis & Systemic Health 11:00 am

Explore the role of adiponectin receptor signalling in modulating inflammation and fibrosis in preclinical models of fibrotic disease Discuss therapeutic strategies aimed at reversing adipose, hepatic, and cardiac tissue fibrosis to reduce multi-organ fibrotic burdenRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.